Petros Pharmaceuticals to Present at the LD Micro Virtual Invitational Conference on June 10, 2021
Petros Pharmaceuticals (Nasdaq: PTPI) announced that President Fady Boctor will present a corporate overview at the LD Micro Virtual Invitational Conference from June 8 to 10, 2021.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Petros Pharmaceuticals (Nasdaq: PTPI) announced that President Fady Boctor will present a corporate overview at the LD Micro Virtual Invitational Conference from June 8 to 10, 2021. Boctor's presentation is scheduled for June 10 at 4:00pm ET, Track 1. Investors can register to watch the presentation here. The company focuses on developing innovative therapeutics for men's health issues, including erectile dysfunction and Peyronie's disease.
Details
News Market Reaction – PTPI
The recorded move for PTPI in the trading session of this news was -3.29%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
NEW YORK, June 2, 2021 /PRNewswire/ -- Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for men's health, today announced that President and Chief Commercial Officer Fady Boctor will present a corporate overview at the three-day LD Micro Virtual Invitational Conference being held on June 8 – 10, 2021.
Mr. Boctor will deliver his corporate presentation on June 10 at 4:00pm ET, Track 1.
Investors can register to watch the presentation here.
Investors interested in scheduling a meeting with management should contact assistant@ldmicro.com.
About Petros Pharmaceuticals
Petros Pharmaceuticals is committed to the goal of becoming a world-leading specialized men's health company by identifying, developing, acquiring, and commercializing innovative therapeutics for men's health issues including, but not limited to erectile dysfunction, endothelial dysfunction, psychosexual and psychosocial ailments, Peyronie's disease, hormone health and substance use disorders.
View original content:http://www.prnewswire.com/news-releases/petros-pharmaceuticals-to-present-at-the-ld-micro-virtual-invitational-conference-on-june-10-2021-301304148.html
SOURCE Petros Pharmaceuticals, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.